Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events how collect robust data pregnancy drug safety
… Outline Best Practices for Collecting Patient Experience Data During the COVID-19 Outbreak Share on: April 9, 2020 … drew on current FDA recommendations for patient-focused drug development (PFDD) and other more emergent regulatory … team using the form on this page to learn more about about how we can partner with you in patient experience data …
… Causal Inference Using Real-World Data: How Pharmacoepidemiology Studies Can Benefit From the Target … Healthcare professionals, policy makers, and patients need robust evidence on the effects of healthcare interventions to … clinical trials and robust information on rare adverse events was lacking. As the availability of real-world data …
… Final FDA Guidance on Real-World Data and Real-World-Evidence for Drug and Biological Products Share on: October 10, 2023 In … RWE in regulatory submissions. Contact us to talk about how we can help with your RWD and RWE research needs. To …
… Regulatory Priorities, Real-World Evidence, and the Safety and Effectiveness of COVID-19 Vaccines Share on: … Sentinel Initiative, launched in 2007 by the US Food and Drug Administration (FDA), is a national electronic data system created to help monitor the safety of …
… RTI International Acquires Medical Data Analytics Share on: April 6, 2020 Combination expands offering of real-world data/real-world evidence (RWD/RWE) to the world’s leading … to expand RTI Health Solutions capacity for delivering a robust and integrated set of project services for our …
… Sentinel Initiative, launched in 2007 by the US Food and Drug Administration (FDA), is a national electronic data system created to help monitor the safety of … inferential studies. Panelists and moderators emphasized how lessons learned during the COVID-19 pandemic can prepare …
… Recent FDA Drug and Device Guidelines for Sharing Pre-Approval … range of information from manufacturers. They can ask for data on product effectiveness, safety, and cost-effectiveness … channel that hasn’t existed before. For help understanding how to develop effective and appropriate dossiers for …
… Cost-Effective Second-Line ADHD Drug with Better Efficacy Reported Share on: August 25, 2016 … Evelina Zimovetz, MSc , and Josephine Mauskopf, PhD, using data from the head-to-head trial, showed that LDX is a … week, found that LDX was associated with a faster and more robust treatment response than atomoxetine, as demonstrated …
… ICER’s 2023 Value Assessment Framework Updates: How Might Changes Impact Pharmaceutical Companies? Share on: … An alternative method for estimating societal costs when data are lacking Potential other benefits and contextual … ICER will conduct key scenarios reflecting changes in drug pricing over time. For example, ICER proposes that the …
… patients and their caregivers to help inform the drug development process. The Alzheimer’s Disease Patient and … any of these conditions. With the scientifically-rigorous data from the study, drug developers will have a better … watch the recording of the launch announcement, and learn how you can join the A-LIST by visiting the …